Skip to main content

Epidemiology and Relative Toxicity of Antidepressant Drugs in Overdose

Drug Safety volume 16, pages 374–390 (1997)Cite this article

Summary

Antidepressant drugs are currently the mainstay of treatment for all but the mildest forms of depression. Their effectiveness in the management of depressive illness is undisputed and their effectiveness in preventing suicide, while not proven, may be assumed. Nevertheless, of all the drugs that are taken in lethal overdose, prescribed antidepressants are among the most common.

Epidemiological studies from several countries have provided evidence of marked differences in overdose toxicity between drug classes and, in some cases, between individual drugs within a class, with some of the older tricyclic anti-depressants (TCAs) being the most toxic.

Over 80% of all deaths arising from overdose of antidepressant medication in the UK between 1987 and 1992 were caused by 2 drugs: amitriptyline and dothiepin. Taken alone, this figure conveys little information about the toxicity of either drug. However, when considered within an epidemiological context, the evidence suggests that both drugs are highly toxic in overdose, a conclusion that is supported by animal studies of the toxicity of TCAs and by clinical evidence of overdose toxicity.

This paper reviews the epidemiological evidence concerning the acute toxicity of antidepressant drugs and considers the interplay of factors that contribute to the toxicity which occurs when they are taken in acute overdose. The inherent toxicity of the drug appears to be the crucial factor and, although less well researched, prescribing practices and perception of toxicity are probable contributory factors.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1995; 305: 1198–202

    Article  Google Scholar 

  2. Montgomery SA, Bebbington P, Cowen P, et al. Guidelines for treating depressive illness with antidepressants. J Psycho-pharmacol 1993; 7: 19–23

    CAS  Google Scholar 

  3. Leonard BE. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993; 54: 3–15

    PubMed  Google Scholar 

  4. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: a meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683–7

    PubMed  Article  CAS  Google Scholar 

  5. Workman EA, Short DD. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis. J Clin Psychiatry 1993; 54: 5–12

    PubMed  CAS  Google Scholar 

  6. Anderson IM, Tomenson BM. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238–49

    PubMed  Article  CAS  Google Scholar 

  7. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995; 9: 33–40

    PubMed  Article  Google Scholar 

  8. Paykel ES, Freeling P, Hollyman JA. Are tricyclic antidepressants useful for mild depression? A placebo-controlled trial. Pharmacopsychiatry 1988; 21: 15–8

    PubMed  Article  CAS  Google Scholar 

  9. Ballinger B. New treatments for depression. Update 1995; 15: 234–7

    Google Scholar 

  10. Montgomery SA. Suicide and antidepressants. Drugs 1992; 43 Suppl.: 24–31

    PubMed  Article  Google Scholar 

  11. Kind P, Sorensen J. The costs of depression. Int Clin Psychopharmacol 1993; 7: 191–5

    PubMed  Article  CAS  Google Scholar 

  12. Stoudemire A, Frank R, Hedemark N, et al. The economic burden of depression. Gen Hosp Psychiatry 1986; 8: 387–94

    PubMed  Article  CAS  Google Scholar 

  13. Diekstra RFW. The epidemiology of suicide and parasuicide. Acta Psychiatr Scand 1993; 371: 9–20

    Article  CAS  Google Scholar 

  14. Kellerman AL, Rivara FP, Somes G, et al. Suicide in the home in relation to gun ownership. N Engl J Med 1992; 327: 467–72

    Article  Google Scholar 

  15. Office of Population Censuses and Surveys. Mortality statistics — accidents and violence (England and Wales), Series DH2. London: HMSO, 1990

    Google Scholar 

  16. Office of Population Censuses and Surveys. Mortality statistics — accidents and violence (England and Wales), Series DH2. London: HMSO, 1991

    Google Scholar 

  17. Office of Population Censuses and Surveys. Mortality statistics - accidents and violence (England and Wales), Series DH2. London: HMSO, 1992

    Google Scholar 

  18. Office of Population Censuses and Surveys. Mortality statistics — accidents and violence (England and Wales), Series DH2. London: HMSO, 1993

    Google Scholar 

  19. Prescott LF, Highley MS. Drugs prescribed for self-poisoners. BMJ 290; 1985: 1633–6

    PubMed  Article  CAS  Google Scholar 

  20. Teige B, Fleischer E. Medikament — og alkoholdodsfall un-dersokt ved Rettsmedisinsk institutt, Universitet I Oslo I arene 1977-1979. Tidsskr Nor Laegeforen 1981; 101: 1563–6

    PubMed  CAS  Google Scholar 

  21. Farmer RDT. Epidemiology of suicide. Int Clin Psychopharmacol 1992; 6 Suppl. 6: 1–11

    PubMed  Article  Google Scholar 

  22. Bolster M, Curran J, Busuttil. A five year review of fatal self-ingested overdoses involving amitriptyline in Edinburgh 1983-87. Hum Exp Toxicol 1994; 13: 29–31

    PubMed  Article  CAS  Google Scholar 

  23. Farmer RDT, Pinder RM. Why do fatal overdose rates vary between antidepressants?. Acta Psychiatr Scand 1989; 80 Suppl. 354: 25–35

    Article  Google Scholar 

  24. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–4

    PubMed  Article  CAS  Google Scholar 

  25. Girdwood RH. Death after taking medicaments. BMJ 1974; 1: 501–4

    PubMed  Article  CAS  Google Scholar 

  26. Barraclough BM. Are there safer hypnotics than barbiturates?. Lancet 1974; I: 57–8

    Article  Google Scholar 

  27. King LA, Moffat AC, Stead AH. Quantitative structure-activity relationships in forensic toxicology. In: Dearden JC, editor. Quantitative approaches to drug design. Oxford: Elsevier, 1983: 277–8

    Google Scholar 

  28. Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987; 295: 1021–4

    PubMed  Article  CAS  Google Scholar 

  29. Henry JA, Antao CA. Suicide and fatal antidepressant poisoning. Eur J Med 1992; 6: 343–8

    Google Scholar 

  30. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995; 5: 5–13

    PubMed  Article  CAS  Google Scholar 

  31. Montgomery SA. The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 1989; 4: 113–9

    PubMed  Article  Google Scholar 

  32. Wakelin JS. The role of serotonin in depression and suicide: do serotonin reuptake inhibitors hold the key? Adv Biol Psychiatry 1988; 17: 70–83

    Google Scholar 

  33. Retterstøl N. Norwegian data on death due to overdose of anti-depressants. Acta Psychiatr Scand 1989; 80 Suppl. 354: 61–8

    Article  Google Scholar 

  34. Vuori E, Klaukka T, Lahti T. Fatal poisonings with antidepressants in Finland 1985–1987. Acta Psychiatr Scand 1989; 80 Suppl. 354: 55–60

    Article  Google Scholar 

  35. Malmvik J, Löwenhielm CGP, Melander A. Antidepressants in suicide: differences in fatality and drug utilisation. Eur J Clin Pharmacol 1994; 46: 291–4

    PubMed  Article  CAS  Google Scholar 

  36. Kapur S, Mieczkowski T, Mann J. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992; 268: 3441–5

    PubMed  Article  CAS  Google Scholar 

  37. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 310; 1995: 215–8

    PubMed  Article  CAS  Google Scholar 

  38. Molcho A, Stanley M. Antidepressants and suicide risk: issues of chemical and behavioural toxicity. J Clin Psychopharmacol 1992; 12 (2 Suppl.): 13S–8S

    PubMed  CAS  Google Scholar 

  39. Kelvin AS, Hakansson S. Comparative acute toxicity of paroxetine and other antidepressants. Acta Psychiatr Scand 1989; 80: 31–3

    Article  Google Scholar 

  40. Dziukas LJ, Vohra J. Tricyclic antidepressant poisoning. Med J Aust 1991; 154: 344–50

    PubMed  CAS  Google Scholar 

  41. Halper JP, Mann JJ. Cardiovascular effects of antidepressant medications. Br J Psychiatry 1988; 153: 87–98

    CAS  Google Scholar 

  42. Pentel PR, Benowitz NL. Tricyclic antidepressant poisoning. Med Toxicol 1986; 1: 101–21

    PubMed  CAS  Google Scholar 

  43. Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med 1985; 14: 1–9

    PubMed  Article  CAS  Google Scholar 

  44. Crome P, Newman B. Why patients die from tricyclic antidepressant poisoning. Vet Hum Toxicol 1979; 21: 56–8

    PubMed  Google Scholar 

  45. Mathews K, Eagles JM, Mathews CA. The use of antidepressant drugs in general practice. Eur J Clin Pharamacol 1993; 45: 205–10

    Article  Google Scholar 

  46. Litovitz TL, Troutman WG. Amoxapine overdose: seizures and fatalities. JAMA 1983; 250: 1069–71

    PubMed  Article  CAS  Google Scholar 

  47. Wedin GP, Oderda GM, Klein-Schwartz W, et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986; 15: 797–804

    PubMed  Article  CAS  Google Scholar 

  48. Yashuhara H, Tonooka M, Kamei K, et al. Membrane effects of various drugs on isolated rat hepatocytes and erythrocytes. Toxicol Appl Pharmacol 1985; 79: 453–60

    Article  Google Scholar 

  49. Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994; 343: 159–62

    PubMed  Article  CAS  Google Scholar 

  50. McGrady H, Rees JA. Toxicity of dothiepin in overdose [letter]. Lancet 1994; 343: 292

    PubMed  Article  CAS  Google Scholar 

  51. Buckley NA, Dawson AH, Whyte IM, et al. Toxicity of dothiepin in overdose [letter]. Lancet 1994; 343: 735

    PubMed  Article  CAS  Google Scholar 

  52. Crome P, Ali P. Clinical features and management of self-poisoning with newer antidepressants. Med Toxicol 1986; 1: 411–20

    PubMed  CAS  Google Scholar 

  53. Reid F, Henry JA. Lofepramine overdosage. Pharmacopsychiatry 1990; 23: 23–7

    PubMed  Article  Google Scholar 

  54. Henry JA, Martin AJ. The risk-benefit assessment of antidepressant drugs. Med Toxicol 1987; 2: 445–62

    CAS  Google Scholar 

  55. Blackwell B. Adverse effects of antidepressant drugs. Drugs 1981; 21: 273–82

    PubMed  Article  CAS  Google Scholar 

  56. Henry JA. Serotonin syndrome [letter]. Lancet 1994; 343: 607

    PubMed  Article  CAS  Google Scholar 

  57. Amrein R, Allen SR, Vranesic D, et al. Antidepressant drug therapy: associated risks. J Neural Transm 1988; 26: 73–86

    CAS  Google Scholar 

  58. Henry JA. Toxicity of antidepressants: comparisons with fluoxetine. Int Clin Psychopharmacol 1992; 6 Suppl. 6: 22–7

    PubMed  Article  Google Scholar 

  59. Fluoxetine: another new antidepressive. Drug Ther Bull 1990; 28: 33–4

    Google Scholar 

  60. Selective serotonin reuptake inhibitors for depression?. Drug Ther Bull 1993; 31: 57–8

    Google Scholar 

  61. Riddle MA, Brown N, Dzubinski D, et al. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989; 28: 587–8

    PubMed  Article  CAS  Google Scholar 

  62. Spiller HA, Morse S, Muir C. Fluoxetine ingestion: a one year retrospective study. Vet Hum Toxicol 1990; 32: 153–5

    PubMed  CAS  Google Scholar 

  63. Borys DJ, Setzer SWC, Ling LJ, et al. The effects of fluoxetine in the overdose patient. Clin Toxicol 1990; 28: 331–40

    Article  CAS  Google Scholar 

  64. Kim SW, Pentel PR. Flu-like symptoms associated with fluoxetine overdose: a case report. Clin Toxicol 1990; 27: 389–93

    Article  Google Scholar 

  65. van den Burgh, H. Citalopram. Product monograph. Copenhagen, Denmark: Lundbeck A/S, 1994

    Google Scholar 

  66. Öström M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348: 339–40

    PubMed  Article  Google Scholar 

  67. Brion F, Brion N, Durigon M. Fatal overdose with citalopram [letter]?. Lancet 1996; 348: 1380

    PubMed  Article  CAS  Google Scholar 

  68. Crome P, Newman B. Poisoning with maprotiline and mianserin. BMJ 1977; 2: 260

    PubMed  Article  CAS  Google Scholar 

  69. Wakeling A. Efficacy and side effects of mianserin, a tetracyclic antidepressant. Postgrad Med J 1983; 59: 229–31

    PubMed  Article  CAS  Google Scholar 

  70. Rouillon F, Phillips R, Serrurier D, et al. Rechutes de depression unnipolaire et efficacite de la maprotiline. L’Encephale 1989; 15: 527–34

    PubMed  CAS  Google Scholar 

  71. Michel K, Arestegui G, Spuhler T. Suicide with psychotropic drugs in Switzerland. Pharmacopsychiatry 1994; 27: 114–8

    PubMed  Article  CAS  Google Scholar 

  72. Inman WHW. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet 1988; II: 90–2

    Article  Google Scholar 

  73. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147: 207–10

    PubMed  CAS  Google Scholar 

  74. Damly NF, Ferguson JH. Paradoxical worsening of depressive symptamology caused by antidepressants. J Clin Psychiatr 1988; 8(5): 347–9

    Google Scholar 

  75. Fava H, Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatr 1991; 52: 108–11

    CAS  Google Scholar 

  76. Beasley CM, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991; 303: 685–92

    PubMed  Article  Google Scholar 

  77. Edwards JG, Inman WHW, Wilton L, et al. Prescription-event monitoring of 10 401 patients treated with fluvoxamine. Br J Psychiatry 1994; 164: 387–95

    PubMed  Article  CAS  Google Scholar 

  78. Broadhead WE, Larson DB, Yarnall KSH, et al. Tricyclic anti-depressants prescribing for nonpsychiatric disorders. J Fam Pract 1991; 33: 24–32

    PubMed  CAS  Google Scholar 

  79. Baldwin DS. How to recognise and treat depressed patients. Med Monit 1993; 58: 56–60

    Google Scholar 

  80. Seager CP, Flood RA. Suicide in Bristol. Br J Psychiatry 1965; 111: 919–32

    PubMed  Article  CAS  Google Scholar 

  81. Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974; 125: 355–73

    PubMed  Article  CAS  Google Scholar 

  82. Katona CLE. Depression and anxiety in old age. Prim Care Psychiatry 1995; 1: 33–6

    Google Scholar 

  83. Montgomery SA, Henry J, McDonald G, et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9: 47–53

    PubMed  Article  CAS  Google Scholar 

  84. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310: 1433–8

    PubMed  Article  CAS  Google Scholar 

  85. Johnson DAW. Non-compliance with antidepressant therapy — an underestimated problem. Int Med Suppl. 11: 14-7

  86. Henry JA. Debits and credits in the management of depression. Br J Psychiatry 1993; 163 Suppl. 20: 33–9

    Google Scholar 

  87. Donoghue JM. The prescribing of antidepressants in general practice: the use of PACT data. Postgrad Med J 1994; 70: S23–4

    PubMed  Article  Google Scholar 

  88. Sener KE, Besbelli N, Henry JA. Importance of pharmaceutical forms in suicide attempts [abstract]. Hum Toxicol 1994; 13: 193A

    Google Scholar 

  89. Buckalew LW, Coffield KE. Drug expectations associated with perceptual characteristics: ethnic factors. Percept Mot Skills 1982; 55: 915–8

    PubMed  Article  CAS  Google Scholar 

  90. Salis RE, Buckalew LW. Relation of capsule colour and perceived potency. Percept Mot Skills 1984; 58: 897–8

    Article  Google Scholar 

  91. Stein B, Volans GN. Dixarit overdose: the problem of attractive tablets. BMJ 1978; 2: 667–8

    PubMed  Article  CAS  Google Scholar 

  92. de Jonghe F, Surinkels JA. The safety of antidepressants. Drugs 1992; 43 Suppl. 2: 135–85

    Google Scholar 

Download references

Author information

Affiliations

  1. Accident and Emergency Department, St Mary’s Hospital, London, W2 1NY, England

    J. A. Henry

Authors
  1. J. A. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Henry, J.A. Epidemiology and Relative Toxicity of Antidepressant Drugs in Overdose. Drug-Safety 16, 374–390 (1997). https://doi.org/10.2165/00002018-199716060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199716060-00004

Keywords

  • Adis International Limited
  • Fluoxetine
  • Amitriptyline
  • Clomipramine
  • Antidepressant Drug